Skip to main content
. 2023 Nov 25;2:100849. doi: 10.1016/j.gimo.2023.100849

Table 1.

NHS England mainstream testing criteria since April 2022 for breast cancer for R208

Living affected individual (proband) with breast or ovarian cancer where the individual +/− family history meets 1 of the criteria. The proband has the following:
  • a.

    Breast cancer (age < 40 years, excluding grade 1 breast cancers), OR

  • b.

    Bilateral breast cancer (age < 50 years), OR

  • c.

    Triple-negative breast cancer (age < 60 years), OR

  • d.

    Male breast cancer (any age), OR

  • e.

    Breast cancer (age <45 years) and a first-degree relative with breast cancer (age <45 years), OR

  • f.

    Pathology-adjusted Manchester score ≥15 or CanRisk score ≥10%

  • g.

    Ashkenazi Jewish ancestry and breast cancer at any age